Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy

Documenti analoghi

• Patients’ choices and eligibility for anti‐amyloid therapy in Japan's universal insurance
  di: Ryoko Ihara, et al.
  Pubblicazione: (2026)
• Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
  di: Saki Nakashima, et al.
  Pubblicazione: (2026)
• Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
  di: Ryosuke Shimasaki, et al.
  Pubblicazione: (2025)
• Intracranial arteriosclerosis is not associated with cerebral amyloid deposition
  di: Anna M. Streiber, et al.
  Pubblicazione: (2024)
• Development of amyloid‐negative neuropsychological norms using GAMLSS
  di: Sara Rubio‐Guerra, et al.
  Pubblicazione: (2025)